SOPHORIDINE – (6882-68-4)

pimobendan, 74150-27-9, pimobendane, Acardi, dl-Pimobendan, Vetmedin, d-Pimobendan, Pimobendan, (-)-, (-)-Pimobendan, Pimobendanum, l-Pimobendan, Racemic pinobendan, (+)-Pimobendan, UD-CG 115, 118428-37-8, UD-CG-115BS, Racemic pimobendan, UD-CG 115 BS, Pimobendan, (+)-, Pimobendan (Vetmedin), UDCG-115, 118428-38-9, UD-CG-115, Pimobendan [INN-Spanish], Pimobendane [INN-French], Pimobendanum [INN-Latin], UNII-34AP3BBP9T, 6-(2-(4-METHOXYPHENYL)-1H-BENZO[D]IMIDAZOL-5-YL)-5-METHYL-4, 5-DIHYDROPYRIDAZIN-3(2H)-ONE, 34AP3BBP9T, 3-[2-(4-methoxyphenyl)-3H-benzimidazol-5-yl]-4-methyl-4, 5-dihydro-1H-pyridazin-6-one, CHEBI:32003, BRN 4207330, CHEMBL24646, rac Pimobendan, 613JXV89SU, 9HTU209Z0N, DTXSID8048280, 3(2H)-Pyridazinone, 4, 5-dihydro-6-(2-(4-methoxyphenyl)-1H-benzimidazol-5-yl)-5-methyl-, (+)-, 3(2H)-Pyridazinone, 4, 5-dihydro-6-(2-(4-methoxyphenyl)-1H-benzimidazol-5-yl)-5-methyl-, (-)-, 6-(2-(4-Methoxyphenyl)-4, 5-dihydro-1H-benzimidazol-5-yl)-5-methyl-3(2H)-pyridazinone, FORTEKOR PLUS COMPONENT PIMOBENDAN, Pimobendan (INN-Spanish), Pimobendane (INN-French), Pimobendanum (INN-Latin), PIMOBENDAN (MART.), PIMOBENDAN [MART.], 3(2H)-Pyridazinone, 4, 5-dihydro-6-(2-(4-methoxyphenyl)-1H-benzimidazol-5-yl)-5-methyl-, 6-[2-(4-methoxyphenyl)-1H-benzimidazol-5-yl]-5-methyl-4, 5-dihydropyridazin-3(2H)-one, PIMOBENDAN (USP-RS), PIMOBENDAN [USP-RS], PIMOBENDAN (EP IMPURITY), PIMOBENDAN [EP IMPURITY], PIMOBENDAN (USP MONOGRAPH), PIMOBENDAN [USP MONOGRAPH], 6-(2-(4-methoxyphenyl)-1H-benzo[d]imidazol-6-yl)-5-methyl-4, 5-dihydropyridazin-3(2H)-one, PIMOBENDAN (EMA EPAR VETERINARY), PIMOBENDAN [EMA EPAR VETERINARY], 3(2H)-PYRIDAZINONE, 4, 5-DIHYDRO-6-(2-(4-METHOXYPHENYL)-1H-BENZIMIDAZOL-5-YL)-5-METHYL-, (+/-)-, 3(2H)-PYRIDAZINONE, 4, 5-DIHYDRO-6-(2-(4-METHOXYPHENYL)-1H-BENZIMIDAZOL-6-YL)-5-METHYL-, (+)-UD-CG 115BS, (-)-UD-CG 115BS, NCGC00274063-01, UNII-613JXV89SU, UNII-9HTU209Z0N, VetmedinChew, Pimobendan [USAN:INN:BAN], Pimobendan?, Pimobendan, USP, Pimobendan EP5, 6-(2-(4-methoxyphenyl)-1H-benzimidazol-5-yl)-5-methyl-4, 5-dihydropyridazin-3(2H)-one, Vetmedin-CA1, Acardi (TN), MFCD00761648, 4, 5-Dihydro-6-[2-(4-methoxyphenyl)-1H-benzimidazol-5-yl]-5-methyl-3(2H)-pyridazinone, Pimobendan (Standard), SolutitionKitsPimobendan, PIMOBENDAN [MI], PIMOBENDAN [INN], PIMOBENDAN [JAN], PIMOBENDAN [USAN], (+)-4, 5-Dihydro-6-(2-(4-methoxyphenyl)-1H-benzimidazol-5-yl)-5-methyl-3(2H)-pyridazinone, (-)-4, 5-Dihydro-6-(2-(4-methoxyphenyl)-1H-benzimidazol-5-yl)-5-methyl-3(2H)-pyridazinone, PIMOBENDAN [WHO-DD], SCHEMBL27623, MLS006010188, Pimobendan (JAN/USAN/INN), PIMOBENDAN [GREEN BOOK], DTXCID9028255, Pimobendan, >=98% (HPLC), HY-B0204R, GLBJJMFZWDBELO-UHFFFAOYSA-N, HMS3655I03, HMS3884C21, KUC109647N, BCP02958, HY-B0204, AC-689, BDBM50282617, s1550, AKOS015851937, AKOS015967705, CCG-267853, DB11450, FP38260, KS-1280, 4, 5-dihydro-6-(2-(4-methoxyphenyl)-1H-benzimidazole-5-yl)-5-methyl-3(2H)-pyridazinone, KSC-210-009, NCGC00274063-04, NCGC00274063-05, 118428-36-7, Pimobendan 100 microg/mL in Acetonitrile, SMR002530068, BCP0726000255, DB-219709, P2779, PIMOBENDAN COMPONENT OF FORTEKOR PLUS, SW219717-1, D01133, SBI-0654181.0001, AB01274800-01, AB01274800_02, EN300-27067685, Q414351, BRD-A84575140-001-02-4, Pimobendan, United States Pharmacopeia (USP) Reference Standard, 4, 5-dihydro-6-[2-(4-methoxy-phenyl)-1h-benzimidazol-5-yl]-5-methyl-3 (2h)-pyridazinone, 4, 5-Dihydro-6-[2-(4-methoxyphenyl)-1H-benzimidazol-6-yl]-5-methyl-3(2H)-pyridazinone, 6-[2-(4-Methoxyphenyl)-3H-benzimidazol-5-yl]-5-methyl-4, 5-dihydro-2H-pyridazin-3-one, Pimobendan for system suitability, European Pharmacopoeia (EP) Reference Standard, (+/-)-4, 5-DIHYDRO-6-(2-(P-METHOXYPHENYL)-5-BENZIMIDAZOLYL)-5-METHYL-3(2H)-PYRIDAZINONE, 6-[2-(4-methoxyphenyl)-1H-1, 3-benzodiazol-6-yl]-5-methyl-2, 3, 4, 5-tetrahydropyridazin-3-one